GROUP ONE TRADING, L.P. - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is and the CUSIP is 21833P953. A total of 1 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q4 2022$6,550
-40.5%
59,300
-11.1%
0.00%
Q3 2022$11,000
-42.1%
66,700
-10.5%
0.00%
Q2 2022$19,000
+58.3%
74,500
+231.1%
0.00%
Q1 2022$12,000
-61.3%
22,500
-55.9%
0.00%
Q4 2021$31,000
-13.9%
51,000
+46.6%
0.00%
Q3 2021$36,000
-72.5%
34,800
-51.5%
0.00%
Q2 2021$131,000
+0.8%
71,800
+8.5%
0.00%
Q1 2021$130,000
+465.2%
66,200
+257.8%
0.00%
Q4 2020$23,000
-97.6%
18,500
-96.5%
0.00%
-100.0%
Q3 2020$941,000
-42.5%
522,800
+168.0%
0.00%
-62.5%
Q2 2020$1,637,000
+343.6%
195,100
+176.7%
0.01%
+166.7%
Q1 2020$369,000
+241.7%
70,500
+257.9%
0.00%
+200.0%
Q4 2019$108,000
-54.4%
19,700
-59.5%
0.00%
-50.0%
Q3 2019$237,000
-45.3%
48,700
-22.1%
0.00%
-50.0%
Q2 2019$433,000
-33.5%
62,500
-33.3%
0.00%
-42.9%
Q1 2019$651,000
-3.3%
93,700
-18.7%
0.01%
+16.7%
Q4 2018$673,000
+4.7%
115,200
+35.2%
0.01%
+20.0%
Q3 2018$643,000
+805.6%
85,200
+508.6%
0.01%
+400.0%
Q2 2018$71,000
-77.3%
14,000
-72.7%
0.00%
-66.7%
Q1 2018$313,000
-8.2%
51,300
+6.9%
0.00%
+50.0%
Q4 2017$341,000
-78.5%
48,000
-78.4%
0.00%
-85.7%
Q3 2017$1,587,000
-15.3%
222,000
-25.4%
0.01%
-26.3%
Q2 2017$1,874,000
-52.9%
297,500
-38.3%
0.02%
-58.7%
Q1 2017$3,980,000
+221.0%
482,400
+228.6%
0.05%
+283.3%
Q4 2016$1,240,000
+1262.6%
146,800
+995.5%
0.01%
+1100.0%
Q3 2016$91,00013,4000.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q1 2023
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 18,500$23,0000.00%
SIMPLEX TRADING, LLC 278$34,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders